The role of impaired iron transport on exercise performance and prognosis in patients with chronic heart failure

铁转运障碍对慢性心力衰竭患者运动能力和预后的影响

阅读:1

Abstract

BACKGROUND: Iron deficiency (ID) is frequent in chronic heart failure (HF). Among HF-ID patients those with impaired iron transport (IIT) (Transferrin saturation (TSAT) < 20 %) have the worst prognosis. In HF survival is strictly related to exercise limitation but the link between IIT, exercise limitation and survival is at present undefined. METHODS: We evaluated in 999 consecutive patients hospitalized for worsening HF whether IIT affects prognosis through cardiopulmonary exercise test (CPET), i.e. peak oxygen uptake (VO(2)) and ventilation vs. carbon dioxide (VE/VCO(2)) slope. In all patients at stabilization iron metabolism and maximal CPET were performed. Survival was assessed as all cause death, urgent LVAD and heart transplant were considered death equivalents. The causal relationship between survival and IIT, peakVO(2) and VE/VCO(2)slope was assessed applying path analysis. RESULTS: PeakVO(2,) VE/VCO(2)slope and TSAT were 68 ± 44 %pred, 35 ± 9 and 24.4 ± 12.9, respectively. PeakVO(2) and(,) VE/VCO(2)slope were 61 ± 18 vs. 72 ± 53 %pred and 38 ± 10 vs. 33 ± 8, in IIT vs. non IIT patients (p < 0.0001 in both). At univariable and multivariable analysis a correlation between survival and VO(2), VE/VCO(2)slope and TSAT was observed; at Kaplan-Myer lower peakVO(2), higher VE/VCO(2)slope and lower TSAT showed worst survival; at path analysis IIT showed both an important effect on survival independent from peakVO(2) and VE/VCO(2)slope (48 %) and an effect on survival independently mediated by VE/VCO(2)slope and peakVO(2) (52 %), contributing to the IIT negative effect on survival. CONCLUSIONS: The adverse impacts of low TSAT on prognosis are in part direct and in part mediated by mechanisms related to reduced peakVO(2) and increased @VE/VCO(2)slope.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。